Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb 7:2010:480260.
doi: 10.4061/2010/480260.

Treatment of advanced Parkinson's disease

Affiliations

Treatment of advanced Parkinson's disease

Sara Varanese et al. Parkinsons Dis. .

Abstract

Patients at late stage Parkinson's disease (PD) develop several motor and nonmotor complications, which dramatically impair their quality of life. These complications include motor fluctuations, dyskinesia, unpredictable or absent response to medications, falls, dysautonomia, dementia, hallucinations, sleep disorders, depression, and psychosis. The therapeutic management should be driven by the attempt to create a balance between benefit and side effects of the pharmacological treatments available. Supportive care, including physical and rehabilitative interventions, speech therapy, occupational therapy, and nursing care, has a key role in the late stage of disease. In this review we discuss the several complications experienced by advance PD patients and their management. The importance of an integrative approach, including both pharmacological and supportive interventions, is emphasized.

PubMed Disclaimer

References

    1. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–442. - PubMed
    1. Hoehn MM. Parkinsonism treated with levodopa: progression and mortality. Journal of Neural Transmission. 1983;19, supplement:253–264. - PubMed
    1. Poewe WH, Wenning GK. The natural history of Parkinson’ disease. Annals of Neurology. 1998;44(3):S1–S9. - PubMed
    1. Poewe WH, Lees AJ, Stern GM. Low-dose L-dopa therapy in Parkinson’s disease: a 6-year follow-up study. Neurology. 1986;36(11):1528–1530. - PubMed
    1. Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson’s disease: a community-based study. Brain. 2000;123(11):2297–2305. - PubMed

LinkOut - more resources